Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



MAZELSKY JONATHAN JAY Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2023 4 MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Paid exercise price by delivering 170 shares @ $504.08, valued at $85.7k
Exercised 384 restricted stock units @ $0
07/17/2023 4 MAZELSKY JONATHAN JAY (Director) has filed a Form 4 on DENTSPLY SIRONA Inc.
Txns: Granted 19 shares @ $0
Granted 1 options to buy @ $41.14, valued at $36.9
06/29/2023 4 MAZELSKY JONATHAN JAY (Director) has filed a Form 4 on DENTSPLY SIRONA Inc.
Txns: Granted 264 options to buy @ $39.58, valued at $10.4k
05/24/2023 3 MAZELSKY JONATHAN JAY (Director) has filed a Form 3 on DENTSPLY SIRONA Inc.
05/19/2023 4 MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Gifted 602 shares @ $0
05/05/2023 4 MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Exercised 560 options to buy @ $178.26, valued at $99.8k
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2022 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Sold 972 shares @ $433.3741, valued at $421.2k
Sold 6,385 shares @ $434.2615, valued at $2.8M
Sold 2,543 shares @ $435.0712, valued at $1.1M
Sold 600 shares @ $435.8775, valued at $261.5k
Exercised 18,998 options to buy @ $62, valued at $1.2M
11/09/2022 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Sold 900 shares @ $378.5951, valued at $340.7k
Sold 2,000 shares @ $379.4994, valued at $759k
Sold 500 shares @ $380.852, valued at $190.4k
Sold 3,704 shares @ $382.8057, valued at $1.4M
Sold 2,716 shares @ $383.2864, valued at $1M
Sold 3,018 shares @ $384.4651, valued at $1.2M
Sold 392 shares @ $385.0122, valued at $150.9k
Exercised 24,002 options to buy @ $52, valued at $1.2M
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2022 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Paid exercise price by delivering 1,423 shares @ $505.53, valued at $719.4k
Granted 22,366 options to buy @ $505.53, valued at $11.3M
Granted 12,557 options to buy @ $556.083, valued at $7M
Granted 197 options to buy @ $505.53, valued at $99.6k
Granted 3,833 restricted stock units @ $0
Exercised 459 restricted stock units @ $0
Exercised 505 restricted stock units @ $0
Exercised 435 restricted stock units @ $0
Exercised 974 restricted stock units @ $0
Exercised 690 restricted stock units @ $0
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2020 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Sold 355 shares @ $463.4548, valued at $164.5k
Sold 1,307 shares @ $465.0234, valued at $607.8k
Sold 107 shares @ $465.8077, valued at $49.8k
Sold 310 shares @ $467.3319, valued at $144.9k
Sold 400 shares @ $468.9235, valued at $187.6k
Sold 714 shares @ $470.3444, valued at $335.8k
Sold 264 shares @ $471.3391, valued at $124.4k
Sold 247 shares @ $473.99, valued at $117.1k
Sold 200 shares @ $475.178, valued at $95k
Sold 300 shares @ $476.73, valued at $143k
Sold 209 shares @ $468.465, valued at $97.9k
08/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2020 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Sold 1,145 shares @ $275.7245, valued at $315.7k
Sold 1,337 shares @ $276.7072, valued at $370k
Sold 3,354 shares @ $277.8769, valued at $932k
Sold 1,676 shares @ $279.0054, valued at $467.6k
Sold 100 shares @ $280.133, valued at $28k
Sold 388 shares @ $281.9705, valued at $109.4k
Exercised 13,824 options to buy @ $45.84, valued at $633.7k
01/16/2020 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Exercised 2,188 options to buy @ $45.84, valued at $100.3k
11/05/2019 4 MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Exercised 27,992 options to buy @ $306.526, valued at $8.6M
08/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2018 4 MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Paid exercise price by delivering 446 shares @ $196.8, valued at $87.8k
Exercised 961 restricted stock units @ $0
02/16/2018 4 MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Paid exercise price by delivering 778 shares @ $178.26, valued at $138.7k
Granted 25,140 options to buy @ $178.26, valued at $4.5M
Granted 560 options to buy @ $178.26, valued at $99.8k
Granted 2,524 restricted stock units @ $0
Exercised 544 restricted stock units @ $0
Exercised 403 restricted stock units @ $0
Exercised 472 restricted stock units @ $0
Exercised 737 restricted stock units @ $0
Exercised 459 restricted stock units @ $0
12/07/2017 4 MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns: Paid exercise price by delivering 471 shares @ $159.78, valued at $75.3k
Exercised 961 restricted stock units @ $0
09/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy